| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 674071 | Null | 0.0393863597626322 | -0.31847878 |
| NSC 674233 | Null | 0.0393863597626322 | -0.18262387 |
| NSC 678994 | 2-Butenedioic acid, 2-(6-aminopurin-9-yl)-, diethylester, (E)- | 0.0393863597626322 | 0.10449634 |
| NSC 685844 | Null | 0.0393863597626322 | 0.23781594 |
| NSC 689227 | 3-Hydroxy-4-[4-[3-(4-isopropylcyclohexanony)butyl]]cyclo pentanone tert-butyldimethylsilyl ether | 0.0393863597626322 | -0.013162615 |
| NSC 692655 | D-Homo-17a-aza-5-androsteno[17,16-c]pyrazol-3-yl,2'-(4-fluorophenyl)-, acetate | 0.0393863597626322 | 0.018250764 |
| NSC 698048 | Null | 0.0393863597626322 | -0.19326486 |
| NSC 699095 | Null | 0.0393863597626322 | 0.058889168 |
| NSC 708244 | Indolo[3,2-d]benzazepin-6(5H)-one, 9-cyano-2,3-dimethoxy-~7,12-dihydro- | 0.0393863597626322 | 0.31003666 |
| NSC 721065 | Null | 0.0393863597626322 | 0.13164618 |